Stock Movers: Marvell, Micron, Eli Lilly
π Marvell Technology (MRVL) and Flex (FLEX) are rising in premarket trading ahead of their scheduled inclusion in the S&P 500 index on June 22.
π° Micron Technology (MU) recently achieved a trillion-dollar market capitalization after rising more than ninefold in the last 12 months.
β οΈ Market strategists are questioning the endurance of Micron's rally due to recent rate-hike expectations and valuation jitters.
π©Ί Eli Lilly (LLY) shares gained following obesity drug presentations at the American Diabetes Association conference.
π Citi analysts view Eli Lilly's incretin portfolio as robust, with Foundayo and retatrutide positioned as category-defining franchises.
- Marvell Technology and Flex are set to be included in the S&P 500 on June 22, which is becoming increasingly important for companies in a market dominated by passive investment funds.
- Micron Technology reached a significant milestone of a trillion-dollar market capitalization in late May, demonstrating strong investor confidence despite recent volatility.
- Eli Lilly shares gained in the early session driven by positive presentations on its obesity drug portfolio at the American Diabetes Association conference.
- Citi analysts maintain firm conviction in Eli Lilly, noting that its incretin portfolio is not reliant on singular blockbusters but rather built on broad development programs.
- Micron Technology's extreme price action has led some market strategists to question how long the current rally can endure.
- Valuation concerns and updrafts in rate-hike expectations, such as Friday's move, could catalyze minor pullbacks in broader indexes including Micron.